Yi Hu

机构：Brigham and Women's Hospital, Harvard University, Tianjin Normal University, Zunyi Medical University, Shanghai University of Sport, Hubei University of Chinese Medicine, Fudan University, Chinese PLA General Hospital, Hunan Agricultural University · ORCID：0000-0002-2800-5650

发表论文 91 篇 · 总被引 1793 次 · h-index 22

代表论文

• Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial (2023 · EBioMedicine · 被引 54)
• Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma (2022 · EBioMedicine · 被引 38)
• Deficiency of lncRNA MERRICAL abrogates macrophage chemotaxis and diabetes-associated atherosclerosis (2024 · Cell Reports · 被引 16)
• Immune microenvironment characteristics in multiple myeloma progression from transcriptome profiling (2022 · Frontiers in Oncology · 被引 10)
• Functional role of circRNA CHRC through miR-431-5p/KLF15 signaling axis in the progression of heart failure (2024 · Journal of genetics and genomics/Journal of Genetics and Genomics · 被引 8)
• Joint association of dietary live microbe intake and depression with cancer survivor in US adults: evidence from NHANES (2025 · BMC Cancer · 被引 6)